TY - JOUR
T1 - Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2
AU - Wei, Xiaochao
AU - Yang, Zhen
AU - Rey, Federico E.
AU - Ridaura, Vanessa K.
AU - Davidson, Nicholas O.
AU - Gordon, Jeffrey I.
AU - Semenkovich, Clay F.
N1 - Funding Information:
We thank Li Yin, Trey Coleman, and Yan Xie for technical expertise, and Maria Karlsson and David O'Donnell for assistance with gnotobiotic mouse experiments. This work was supported by NIH grants DK076729, DK088083, DK20579, DK56341, DK52574, DK56260, HL38180, and DK70977; by the American Heart Association (Postdoctoral Fellowship Award); and by the American Diabetes Association (Mentor-Based Postdoctoral Fellowship Award).
PY - 2012/2/16
Y1 - 2012/2/16
N2 - The intestinal mucus barrier prevents pathogen invasion and maintains host-microbiota homeostasis. We show that fatty acid synthase (FAS), an insulin-responsive enzyme essential for de novo lipogenesis, helps maintain the mucus barrier by regulating Mucin 2, the dominant mucin in the colon and a central component of mucus. Inducible Cre recombinase-directed inactivation of the FAS gene in the colonic epithelium of mice is associated with disruptions in the intestinal mucus barrier as well as increased intestinal permeability, colitis, systemic inflammation, and changes in gut microbial ecology. FAS deficiency blocked the generation of palmitoylated Mucin 2, which must be S-palmitoylated at its N terminus for proper secretion and function. Furthermore, a diabetic mouse model exhibited lower FAS levels and a decreased mucus layer, which could be restored with insulin treatment. Thus, the role of FAS in maintaining intestinal barrier function may explain the pathogenesis of intestinal inflammation in diabetes and other disorders.
AB - The intestinal mucus barrier prevents pathogen invasion and maintains host-microbiota homeostasis. We show that fatty acid synthase (FAS), an insulin-responsive enzyme essential for de novo lipogenesis, helps maintain the mucus barrier by regulating Mucin 2, the dominant mucin in the colon and a central component of mucus. Inducible Cre recombinase-directed inactivation of the FAS gene in the colonic epithelium of mice is associated with disruptions in the intestinal mucus barrier as well as increased intestinal permeability, colitis, systemic inflammation, and changes in gut microbial ecology. FAS deficiency blocked the generation of palmitoylated Mucin 2, which must be S-palmitoylated at its N terminus for proper secretion and function. Furthermore, a diabetic mouse model exhibited lower FAS levels and a decreased mucus layer, which could be restored with insulin treatment. Thus, the role of FAS in maintaining intestinal barrier function may explain the pathogenesis of intestinal inflammation in diabetes and other disorders.
UR - http://www.scopus.com/inward/record.url?scp=84863127054&partnerID=8YFLogxK
U2 - 10.1016/j.chom.2011.12.006
DO - 10.1016/j.chom.2011.12.006
M3 - Article
C2 - 22341463
AN - SCOPUS:84863127054
SN - 1931-3128
VL - 11
SP - 140
EP - 152
JO - Cell Host and Microbe
JF - Cell Host and Microbe
IS - 2
ER -